Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTandem Group Regulatory News (TND)

Share Price Information for Tandem Group (TND)

Share Price is delayed by 15 minutes
Get Live Data
173.50    1.00 (0.58%)
Bid:
170.00
Ask:
177.00
Spread: 7.00 (4.118%)
Market Cap: £9.57m
TND Live PriceLast checked at - London Stock Exchange

Intraday Tandem Group Share Chart

AGM Trading Statement

24 Jun 2025 07:00

RNS Number : 0594O
Tandem Group PLC
24 June 2025
 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

24 June 2025

Tandem Group plc

(the 'Group' or the 'Company')

AGM Trading Statement

 

Tandem Group plc (AIM: TND), designers, developers, distributors and retailers of sports, leisure and mobility equipment, announces that at the Annual General Meeting of the Company to be held today at 11.00 am the Company's Chairman, Steve Grant, will make the following statement:

We are pleased to report that Tandem remains on track to meet market expectations for the financial year ending 31 December 2025.

At 31 May 2025, our Group sales position overall is ahead of the prior year by 15% and we have been focussing heavily on introducing newness to our product range, ensuring that our offerings align with current trends and maintain a high level of innovation.

With the UK enjoying record sunshine this spring, favourable weather has provided a welcome boost for our seasonally dependent products. However, we continue to operate in what remains a challenging environment shaped by ongoing inflationary pressures, rising employment costs and fluctuating consumer confidence. Despite this backdrop, the Group's resilience, and our focus on execution, positions us well for the remainder of the current year and beyond.

In our Toys, Sports, and Leisure division we are currently tracking 6% behind the same period last year. This is in line with Board expectations due to the shift in phasing towards the second half of the year, where we anticipate stronger FOB results. Looking ahead to the rest of 2025, we have a robust pipeline of brands and licenses planned.

Our Bikes division has delivered impressive growth, outperforming the market across each of the pedal, electric, and junior categories. Sales are up 52% year to date. Our newness and innovation across all categories have been instrumental in driving an excellent performance year to date.

We are looking forward to the upcoming launch of the new HOY children's bike range, developed in collaboration with cycling legend Sir Chris Hoy. This exciting new range, consisting of eight models, is set to launch in early September 2025, with dealers already placing an encouraging level of pre-orders.

In the Golf division, there has been a change in our sales pattern versus last year. Sales year to date are 6% behind the same period last year. This is mainly due to our Freight-On-Board (FOB) order phasing which has transitioned towards summer, driven by the introduction of our new 2025 range and is therefore again in line with Board expectations.

Our Home and Garden division has seen a sales increase of 14%, with growth supported by the introduction of new categories including outdoor heating, outdoor rugs, internal storage, home décor and the driest spring in over a century, which has positively impacted demand. Looking ahead to the second half of the year, this division will also launch additional innovative and on-trend products to further strengthen our offering.

 

Group Outlook

Refreshment and elevation of the Group's product range is a continuous process that remains essential to the Company's long-term success. We have continued to keep tight control of our costs, whilst developing new sales channels and forging new relationships with customers.

Conditions remain challenging but we are working closely with our European and Asian suppliers to improve our competitiveness and introducing more innovation across our ranges.

With our improved product range and cost control enabling keen pricing, we are looking to grow our sales to new UK customers. The Group also now has dedicated resource to grow sales into Europe.

In summary, the Board remains confident in Tandem's ability to meet market expectations for the current year. We are focussed on improving returns and on recommencing the payment of dividends as soon as trading performance and cashflow permits.

 

 Enquiries:

Tandem Group plc

Peter Kimberley, Chief Executive

Gurvinder Kaur, Company Secretary

Telephone 0121 748 8000

 

Nominated Adviser

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Ben Jeynes / Callum Davidson - Corporate Finance

Michael Johnson / Jamie Anderson - Sales and Equity Capital Markets

Telephone 020 7220 0500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDXLFLEQLFBBZ
Date   Source Headline
19th Jun 202612:00 pmRNSHolding(s) in Company
17th Jun 20264:01 pmRNSResult of AGM
17th Jun 20267:00 amRNSAGM Trading Statement
23rd Mar 20267:00 amRNSFinal Results
6th Feb 20267:00 amRNSTrading Update and Notice of Results
20th Oct 202512:24 pmRNSDirector/PDMR Shareholding
14th Oct 202511:53 amRNSDirector/PDMR Shareholding
6th Oct 202511:56 amRNSDirector/PDMR Shareholding
29th Sep 20259:28 amRNSDirector/PDMR Shareholding
26th Sep 20257:00 amRNSInterim Results
2nd Jul 20252:06 pmRNSDirector/PDMR Shareholding
1st Jul 20253:57 pmRNSDirector/PDMR Shareholding
24th Jun 20252:22 pmRNSResult of Annual General Meeting
24th Jun 20257:00 amRNSAGM Trading Statement
2nd Jun 20257:00 amRNSTotal Voting Rights
8th Apr 20255:45 pmRNSGrant of Options & Surrender of Existing Options
7th Apr 202511:30 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSFinal Results
11th Mar 20257:00 amRNS-RExclusive Partnership for New Bike Range
5th Feb 20257:00 amRNSTrading Update and Notice of Results
31st Jan 20257:00 amRNSDirectorate Changes
17th Oct 202411:15 amRNSDirectorate Change and Relationship Agreement
19th Sep 20247:00 amRNSHalf-year Report
31st Jul 20249:14 amRNSHolding(s) in Company
23rd Jul 20243:55 pmRNSAppointment of Chief Financial Officer
26th Jun 202412:29 pmRNSResult of AGM
26th Jun 20247:00 amRNSAGM Statement
27th Mar 20244:36 pmRNSGrant of Share Options
25th Mar 20247:00 amRNSFinal Results
27th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20243:31 pmRNSGrant of Share Options
5th Feb 20245:15 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSTrading Update and Notice of Results
10th Jan 202411:27 amRNSHolding(s) in Company
13th Dec 20232:19 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSTrading Update
6th Nov 202311:51 amRNSChange of Nominated Adviser and Broker
29th Sep 202310:36 amRNSDirector/PDMR Shareholding
25th Sep 202311:07 amRNSHolding(s) in Company
21st Sep 20234:42 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSHalf Yearly Report
29th Jun 20234:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
11th May 20234:44 pmRNSDirector/PDMR Shareholding
3rd Apr 20234:20 pmRNSPDMR Transaction
28th Mar 20235:09 pmRNSGrant of share options
27th Mar 20237:00 amRNSFinal Results
24th Feb 202312:36 pmRNSExercise of Options and Total Voting Rights
9th Feb 20237:00 amRNSDirectorate Change
1st Feb 20237:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.